Over a five-and-a-half-year period, there were 298 laboratory requests for urinary 5-hydroxyindoleacetic acid (5-HIAA). Traditionally, the reason for a laboratory request for urinary 5-HIAA is to confirm the presence of a carcinoid tumour. We review the clinical and laboratory associations of the 24 cases from Beaumont and James Connolly Memorial Hospitals where at least one 24-h urinary collection for 5-HIAA was greater than the reference range during the five-and-a-half years from 1989 and the problems of a false positive urinary 5-HIAA are discussed.
Summary
Over a five-and-a-half-year period, there were 298 laboratory requests for urinary 5-hydroxyindoleacetic acid A brief clinical summary of the patients with raised urinary 5-HIAA is outlined. Three of the four carcinoid tumours were histologically confirmed. Two originated in the ileum, one in the caecum and the primary site was unknown in the fourth. Each had liver metastases. In case 1, there was a raised HMMA of 66 pmol/l and HVA of 48 ptmol/l whereas these metabolites were normal in the other three. In two of the carcinoids, the diagnosis was unsuspected and was made histologically postoperatively. All four had carcinoid symptoms on clinical review.
The two phaeochromocytomas were histologically confirmed and the elevated 5-HIAAs had corresponding values for free catecholamines, HMMA and HVA which were normal during that particular collection, one of which was pre-operative. One female patient (case 7) with a presumed gut hormone problem, despite batteries of gut hormone analyses at supraregional centres in London, England, and Belfast, Northern Ireland, which had proved negative, complained of watery diarrhoea and a facial rash with flushing. Glucagonoma had been specifically excluded. Episodic severe hypotension compromising her renal function occurred and abdominal ultrasound and CT scans proved normal. An earlier 5-HIAA collection in another hospital had been normal. In case 8, weight loss, diarrhoea, episodic asthma, oesophagitis and hyperreninaemic hypertension were present but CT and MIBG scans and urinary free catecholamines were negative. Lisinopril and ranitidine was the drug therapy and the cause of the elevated 5-HIAA levels of 81.6 remained enigmatic. In case 9, sweating, flushing and occasional palpitations were present. Telangiectasia were present as was an acoustic neuroma. Drug therapy included diltiazem and the presence of carcinoid tumour remains a possibility. Malignant neuroleptic syndrome was diagnosed in a patient from a psychiatric hospital in whom the urinary HMMA, HVA, noradrenaline, adrenaline and dopamine were all elevated but where the free catecholamines returned to normal and the metabolites to almost normal within days. However, in the absence of diagnostic imaging, the diagnosis appears unsafe. 
